Literature DB >> 12773700

Zinc accumulation in N-methyl-N-nitrosourea-induced rat mammary tumors is accompanied by an altered expression of ZnT-1 and metallothionein.

R Lee1, W Woo, B Wu, A Kummer, H Duminy, Z Xu.   

Abstract

Zinc is essential for cell proliferation. Several human studies have shown that in breast cancer tissues, zinc concentration expressed on a per tissue weight basis is higher than that in normal breast tissues. However, the mechanisms involved are unknown. N-methyl-N-nitrosourea (MNU)-induced rat mammary tumorigenesis is one of the most widely used rodent mammary tumorigenesis models for studying human breast cancer due to their similarities in hormone dependency, pathogenesis, histological classification, and immunocytochemical markers. This study was to establish if there was an accumulation of zinc in MNU-induced rat mammary tumors and, if there was, to explore the possible mechanisms involved. Sprague-Dawley rats were sham-treated or MNU-treated (50 mg/kg; n = 12) for 100 days. In MNU-induced mammary tumors (mammary tumors), zinc concentration expressed on a per dry weight basis was 12 times of that in normal mammary glands. Moreover, the mRNA level of ZnT-1 (a transporter involved in zinc efflux) in mammary tumors was reduced by 55% as compared with that in normal mammary glands. The mRNA level of Nramp2 (a divalent cation importer) and ZnT-4 (another transporter involved in zinc efflux) was unaffected by MNU-induced mammary tumorigenesis. The mRNA and protein levels of metallothionein (a putative zinc storage protein) in mammary tumors were 1.3 and 3.5 times of that in normal mammary glands, respectively. Collectively, our observations showed that zinc is accumulated in MNU-induced rat mammary tumors and this accumulation is accompanied by an altered expression of ZnT-1 and metallothionein, suggesting that zinc homeostasis might be altered in MNU-induced rat mammary tumorigenesis. Because zinc is essential to cell proliferation and cell proliferation is increased in mammary tumors, zinc accumulation is likely a part of an integrated effort to ensure sufficient zinc supply to sustain tumor growth.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773700

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  19 in total

1.  Regulation of zinc transporters by dietary zinc supplement in breast cancer.

Authors:  Daoxu Sun; Lianying Zhang; Yongsheng Wang; Xiaolei Wang; Xiaoyan Hu; Fu-Ai Cui; Feng Kong
Journal:  Mol Biol Rep       Date:  2007-05-01       Impact factor: 2.316

2.  Mammary gland zinc metabolism: regulation and dysregulation.

Authors:  Shannon L Kelleher; Young Ah Seo; Veronica Lopez
Journal:  Genes Nutr       Date:  2009-04-02       Impact factor: 5.523

3.  Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts.

Authors:  Min Li; Yuqing Zhang; Uddalak Bharadwaj; Qihui Jim Zhai; Charlotte H Ahern; William E Fisher; F Charles Brunicardi; Craig D Logsdon; Changyi Chen; Qizhi Yao
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

4.  ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer.

Authors:  Xiaobo Cui; Yuqing Zhang; Jingxuan Yang; Xiaotian Sun; John P Hagan; Sushovan Guha; Min Li
Journal:  Cell Cycle       Date:  2014-02-11       Impact factor: 4.534

5.  The metal-responsive transcription factor-1 protein is elevated in human tumors.

Authors:  Yihui Shi; Khalid Amin; Barbara G Sato; Steven J Samuelsson; Lidia Sambucetti; Zishan A Haroon; Keith Laderoute; Brian J Murphy
Journal:  Cancer Biol Ther       Date:  2010-03-20       Impact factor: 4.742

6.  The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate.

Authors:  S T Russell; P M A Siren; M J Siren; M J Tisdale
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

7.  Gene profile identifies zinc transporters differentially expressed in normal human organs and human pancreatic cancer.

Authors:  J Yang; Y Zhang; X Cui; W Yao; X Yu; P Cen; S E Hodges; W E Fisher; F C Brunicardi; C Chen; Q Yao; M Li
Journal:  Curr Mol Med       Date:  2013-03       Impact factor: 2.222

8.  Paradoxical zinc toxicity and oxidative stress in the mammary gland during marginal dietary zinc deficiency.

Authors:  Zeynep Bostanci; Ronald P Mack; Sooyeon Lee; David I Soybel; Shannon L Kelleher
Journal:  Reprod Toxicol       Date:  2014-08-01       Impact factor: 3.143

9.  Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression.

Authors:  Min Li; Yuqing Zhang; Zijuan Liu; Uddalak Bharadwaj; Hao Wang; Xinwen Wang; Sheng Zhang; Juan P Liuzzi; Shou-Mei Chang; Robert J Cousins; William E Fisher; F Charles Brunicardi; Craig D Logsdon; Changyi Chen; Qizhi Yao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

10.  Regulation of zinc transporters by dietary flaxseed lignan in human breast cancer xenografts.

Authors:  Lian-ying Zhang; Xiao-lei Wang; Dao-xu Sun; Xian-xi Liu; Xiao-yan Hu; Feng Kong
Journal:  Mol Biol Rep       Date:  2007-09-05       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.